BUSINESSJun 9 · 01:25 UTCBLOOMBERGKaren Leigh

GSK in Talks to Buy Nuvalent for More Than $9 Billion: FT

GSK is in discussions to acquire Nuvalent for more than $9 billion, according to the Financial Times. The potential deal could significantly expand GSK's portfolio.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

GSKorganizationNuvalentorganizationFinancial Timesorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSApr 29 · 11:05 UTC
Chiesi Agrees to Buy KalVista Pharmaceuticals for $1.9 Billion
BUSINESSMay 20 · 06:00 UTC
Africa’s Biggest Fund Manager in Talks to Buy Stake in Balwin
BUSINESSApr 28 · 08:10 UTC
Eneos Is Said to Be in Final Talks for Chevron Asian Assets
BUSINESSMay 8 · 19:29 UTC
STAT+: Roche to buy PathAI for $750 million
BUSINESSApr 24 · 17:32 UTC
Ethereum news: Bitmine (BMNR) to buy 10,000 ETH for $23.8M from Ethereum Foundation
BUSINESSJun 1 · 11:07 UTC
Berkshire Hathaway to Acquire Taylor Morrison in a $6.8 Billion Deal